GIJC21

Lessons from the Pandemic: COVID-19 and Health-Pharma Investigations

By |

During the COVID-19 pandemic, journalists worldwide were suddenly thrown into the public health beat, trying to make sense of competing claims, and a science that seemed to change by the day. A session at the GIJC21 walked reporters through the COVID-19 pandemic, offering tips on covering the drug development and approval processes, evaluating scientific studies, unearthing conflicts of interest, and exposing fraud and malpractice.

AVROTROS

Health and Medicine Guide: Chapter 4

By |

 

First, Do No Harm. Reporting About Safety
Once a pharmaceutical product — a drug, vaccine, or medical device — has gone through the different testing phases, and the approval process with regulatory agencies, it hits the market and can be prescribed and sold.